Considering that the most commonly mutated gene is TP53 in HNSCCs, researchers are investigating how these mutations influence HNSCC progression and treatment response, as well as their potential as prognostic and predictive biomarkers.94 Here, TP53 is linked to head and neck squamous cell carcinoma.